article thumbnail

What Are The Most Common Conditions MMJ Is Prescribed For?

MMJ Recs

As the medical community delves into the therapeutic potential of cannabis, certain health conditions have emerged as primary candidates for its prescription. THC, the psychoactive component of cannabis, has analgesic properties that can help manage chronic pain conditions, such as neuropathic pain and arthritis.

article thumbnail

Oregon is Setting the Foundation for its Psilocybin Therapy Program

Veriheal

The first legal psilocybin therapy program to take shape in America is slowly progressing in Oregon. Kate Brown conducts regularly scheduled monthly meetings with a goal of shaping the nation’s first Psilocybin therapy program. Oregon’s Psilocybin Therapy Program: Advisory Board Hard at Work. ” . .”

Therapy 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Cannabis Law Report

We are excited to explore the potential of emergent psychedelic therapies. Patients deserve more options, and to be assured of the safety and efficacy of their treatments; similarly, physicians deserve answers and are a critical partner in the development of this new therapeutic class,” says Erin Prosk , President of Santé.

article thumbnail

Study: Cannabis Safe and Effective in Fibromyalgia Patients

NORML

Eight-one percent of subjects reported “at least moderate improvement in their condition … without experiencing serious adverse events.” ” Patients were most likely to report overall reductions in pain and overall improvements in their quality of life following cannabis therapy.

Patients 279
article thumbnail

Understanding the Endocannabinoid System: A Guide for Medical Marijuana Patients

MMJ Recs

Dysfunction in the ECS has been linked to a range of health conditions, highlighting its significance in maintaining overall physiological balance and promoting well-being. In these conditions, alterations in endocannabinoid signaling pathways may contribute to aberrant neuronal activity, neuroinflammation, and neurodegeneration.

Patients 105
article thumbnail

Webinar 9 December: Ethics, Safety, and Abuse in Psychedelic Medicine

Cannabis Law Report

Ethics, Safety, and Abuse in Psychedelic Medicine. She began researching MDMA in 2004 and has worked on studies of psychedelics and mental health conditions at universities, NIH, and MAPS. Vilmarie received a certificate in psychedelic therapies and research from the California Institute of Integral Studies in 2018.

Safety 52
article thumbnail

Press Release: MAPS and Vine Ventures Pioneer Novel Regenerative Funding Structure to Infuse Psychedelic-Assisted Therapy Research and Access With Timely $70 Million

Cannabis Law Report

Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once certain financial milestones are met.

Therapy 52